On the SGX, Riverstone Holdings stands out for its focus on high-quality nitrile and latex gloves, making its share price a point of interest for those following the medical supplies industry.

Its customer base includes medical institutions as well as companies in technology and life sciences sectors, reflecting strong global demand.

When the pandemic drove up glove demand worldwide, Riverstone’s business and share price both saw a boost.

After the initial boom, prices stabilised as more producers entered the market and supply normalised.

Investors often monitor news about here expansion plans or diversification into higher-value products, which can affect future growth and profitability.

Global trends such as flu outbreaks or increased focus on hygiene may temporarily lift glove demand, while oversupply or falling raw material prices may put pressure on margins and the share price.

To sum up, Riverstone is a stock that moves with global health trends and supply-demand shifts in the glove market.